Nanoparticles as computed tomography contrast agents: current status and future perspectives.

The importance of computed tomography (CT) as one of the leading radiology technologies applied in the field of biomedical imaging escalated the development of nanoparticles as the next generation CT contrast agents. Nanoparticles are expected to play a major role in the future of medical diagnostics due to their many advantages over the conventional contrast agents, such as prolonged blood circulation time, controlled biological clearance pathways and specific molecular targeting capabilities. This paper will describe the basic design principles of nanoparticle-based CT contrast agents and review the state-of-the-art developments and clinical applications of blood pool, passive and active targeting CT contrast agents.

[1]  Jack Baniel,et al.  Radiopaque iodinated polymeric nanoparticles for X-ray imaging applications. , 2007, Biomaterials.

[2]  Y. Magata,et al.  X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in PEGylated dendrimer. , 2010, Nanotechnology.

[3]  Dong Liang,et al.  Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. , 2009, Biomaterials.

[4]  P. Fitzgerald,et al.  Synthesis, characterization, and computed tomography imaging of a tantalum oxide nanoparticle imaging agent. , 2010, Chemical communications.

[5]  Stan W. Casteel,et al.  Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity , 2010, Proceedings of the National Academy of Sciences.

[6]  Gert Storm,et al.  Sheddable Coatings for Long-Circulating Nanoparticles , 2007, Pharmaceutical Research.

[7]  K. Sandvig,et al.  New metal-based nanoparticles for intravenous use: requirements for clinical success with focus on medical imaging. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[8]  Chenjie Xu,et al.  Size and Concentration Effect of Gold Nanoparticles on X-ray Attenuation As Measured on Computed Tomography. , 2008, Chemistry of materials : a publication of the American Chemical Society.

[9]  J. Schlomka,et al.  Computed tomography in color: NanoK-enhanced spectral CT molecular imaging. , 2010, Angewandte Chemie.

[10]  James Nyagilo,et al.  Gold nanotags for combined multi-colored Raman spectroscopy and x-ray computed tomography , 2010, Nanotechnology.

[11]  B. Hamm,et al.  Evaluation of liposomal contrast agents for liver CT in healthy rabbits. , 1999, Investigative radiology.

[12]  Horst Weller,et al.  Ligand design and bioconjugation of colloidal gold nanoparticles. , 2002, Angewandte Chemie.

[13]  Leaf Huang,et al.  Pharmacokinetics and biodistribution of nanoparticles. , 2008, Molecular pharmaceutics.

[14]  Bengt Fadeel,et al.  Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. , 2011, Biochimica et biophysica acta.

[15]  Zahi A. Fayad,et al.  Perspectives and opportunities for nanomedicine in the management of atherosclerosis , 2011, Nature Reviews Drug Discovery.

[16]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[17]  G. Schuhmann-Giampieri,et al.  Characterization of Iopromide Liposomes , 1993, Investigative radiology.

[18]  Helinor J Johnston,et al.  A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity , 2010, Critical reviews in toxicology.

[19]  M. Ter-pogossian,et al.  Lymph‐node concentration of radioactive colloidal gold following interstitial injection , 1953, Cancer.

[20]  Jinatta Jittiwat,et al.  Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. , 2010, Biomaterials.

[21]  H. Zentgraf,et al.  Anti-CD4-targeted gold nanoparticles induce specific contrast enhancement of peripheral lymph nodes in X-ray computed tomography of live mice. , 2010, Nano letters.

[22]  J F Hainfeld,et al.  Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions. , 2011, The British journal of radiology.

[23]  J Szebeni,et al.  Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.

[24]  G. Wolf.  Magnetic resonance imaging and the future of cardiac imaging. , 1989, The American journal of cardiology.

[25]  R. Sperling,et al.  Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles , 2010, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[26]  François Hallouard,et al.  Iodinated blood pool contrast media for preclinical X-ray imaging applications--a review. , 2010, Biomaterials.

[27]  Soo Won Seo,et al.  Nanoparticulate carrier containing water-insoluble iodinated oil as a multifunctional contrast agent for computed tomography imaging. , 2007, Biomaterials.

[28]  Giovanni Lucignani,et al.  PET, CT and MRI characterisation of the atherosclerotic plaque , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  Michael J Sailor,et al.  Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. , 2009, Cancer research.

[30]  R. Müller,et al.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.

[31]  Kostas Kostarelos,et al.  Physiologically based pharmacokinetic modeling of nanoparticles. , 2010, ACS nano.

[32]  C. Bremer,et al.  Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits. , 2002, Radiology.

[33]  V. Torchilin,et al.  CT visualization of blood pool in rats by using long-circulating, iodine-containing micelles. , 1999, Academic radiology.

[34]  Pei-Xun Liu,et al.  Toxicologic effects of gold nanoparticles in vivo by different administration routes , 2010, International journal of nanomedicine.

[35]  Priyabrata Mukherjee,et al.  Gold nanoparticles: opportunities and challenges in nanomedicine , 2010, Expert opinion on drug delivery.

[36]  Ehsan Samei,et al.  Micro-CT imaging of breast tumors in rodents using a liposomal, nanoparticle contrast agent , 2009, International journal of nanomedicine.

[37]  S. Seltzer,et al.  Liposomes carrying diatrizoate. Characterization of biophysical properties and imaging applications. , 1984, Investigative radiology.

[38]  A. D. Watson,et al.  Metal-Based X-ray Contrast Media. , 1999, Chemical reviews.

[39]  Ivan H. El-Sayed,et al.  Nanotechnology in Head and Neck Cancer: The Race Is On , 2010, Current oncology reports.

[40]  Philippe Robert,et al.  Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.

[41]  Y. Jeong,et al.  Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. , 2007, Journal of the American Chemical Society.

[42]  Science to practice: can CT be performed for multicolor molecular imaging? , 2010, Radiology.

[43]  Chad A. Mirkin,et al.  Gold nanoparticles for biology and medicine. , 2010, Angewandte Chemie.

[44]  L. Hedlund,et al.  A liposomal nanoscale contrast agent for preclinical CT in mice. , 2006, AJR. American journal of roentgenology.

[45]  Samuel Woojoo Jun,et al.  Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping. , 2011, Journal of the American Chemical Society.

[46]  Cory Berkland,et al.  Iodinated NanoClusters as an inhaled computed tomography contrast agent for lung visualization. , 2010, Molecular pharmaceutics.

[47]  Kwon-Ha Yoon,et al.  Colloidal Gold Nanoparticles as a Blood-Pool Contrast Agent for X-ray Computed Tomography in Mice , 2007, Investigative radiology.

[48]  Raghuraman Kannan,et al.  Gold nanoparticle contrast in a phantom and juvenile swine: models for molecular imaging of human organs using x-ray computed tomography. , 2010, Academic radiology.

[49]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[50]  Klaas Nicolay,et al.  Block-copolymer-stabilized iodinated emulsions for use as CT contrast agents. , 2010, Biomaterials.

[51]  Mingwu Shen,et al.  Computed tomography imaging of cancer cells using acetylated dendrimer-entrapped gold nanoparticles. , 2011, Biomaterials.

[52]  Axel Thran,et al.  Atherosclerotic Plaque Composition : Analysis with Multicolor CT and Targeted Gold Nanoparticles 1 , 2010 .

[53]  Dohyung Lim,et al.  Heparin-coated gold nanoparticles for liver-specific CT imaging. , 2009, Chemistry.

[54]  C. Soto,et al.  Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. , 2010, Biochemical and biophysical research communications.

[55]  A. Popovtzer,et al.  Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study , 2011, International journal of nanomedicine.

[56]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[57]  Vincent M Rotello,et al.  Gold nanoparticles in delivery applications. , 2008, Advanced drug delivery reviews.

[58]  Jan Grimm,et al.  An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles , 2006, Nature materials.

[59]  Manuela Semmler-Behnke,et al.  Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. , 2010, Biomaterials.

[60]  Weimin Fan,et al.  Nanoparticles for tumor targeted therapies and their pharmacokinetics. , 2010, Current drug metabolism.

[61]  Younan Xia,et al.  Targeting gold nanocages to cancer cells for photothermal destruction and drug delivery , 2010, Expert opinion on drug delivery.

[62]  Meifang Zhu,et al.  Acetylation of dendrimer-entrapped gold nanoparticles: Synthesis, stability, and X-ray attenuation properties , 2011 .

[63]  Mark E. Davis,et al.  Targeting kidney mesangium by nanoparticles of defined size , 2011, Proceedings of the National Academy of Sciences.

[64]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.

[65]  Zahi A Fayad,et al.  Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography , 2007, Nature Medicine.

[66]  Zahi A. Fayad,et al.  Imaging of atherosclerotic cardiovascular disease , 2008, Nature.

[67]  J F Hainfeld,et al.  Gold nanoparticles: a new X-ray contrast agent. , 2006, The British journal of radiology.

[68]  S. Bartling,et al.  Radiopaque iodinated copolymeric nanoparticles for X-ray imaging applications. , 2007, Biomaterials.

[69]  Raoul Kopelman,et al.  Targeted gold nanoparticles enable molecular CT imaging of cancer. , 2008, Nano letters.

[70]  D L Rubin,et al.  Blood pool and liver enhancement in CT with liposomal lodixanol: comparison with lohexol. , 1999, Academic radiology.

[71]  S. Wagner,et al.  Preparation and Evaluation of Lyophilized Iopromide‐Carrying Liposomes for Liver Tumor Detection , 1993, Investigative radiology.

[72]  Ananth Annapragada,et al.  Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging. , 2011, Academic radiology.

[73]  A. Sachse,et al.  Biodistribution and Ct-Imaging Characteristics of Iopromide-Carrying Liposomes in Rats , 1996 .

[74]  Woo Jin Hyung,et al.  Liposomes Coloaded with Iopamidol/Lipiodol as a RES-Targeted Contrast Agent for Computed Tomography Imaging , 2010, Pharmaceutical Research.